Skip to main content

Aclarion, Inc.

corporate_fare Company Profile

Aclarion, Inc.

ACON·NASDAQ·Industrial Applications And Services·CIK 0001635077

Aclarion is a healthcare technology company that uses Magnetic Resonance Spectroscopy ("MRS") and proprietary biomarkers to optimize clinical treatments. The company addresses the $134.5B U.S. low back and neck pain market. Aclarion's technology is initially focused on improving outcomes for surgical interventions to treat chronic discogenic low back pain. In this application, the technology assists surgeons in determining the optimal surgical procedure for patients undergoing surgery for pain isolated to their lumbar spine, which consists of the five lower vertebrae, L-1 to L-5. The company currently uses Artificial Intelligence ("AI") to assist in quality control processes by flagging spectroscopy data that indicates a poor MRS study. Aclarion is collecting raw and post-processed spectral data from every Nociscan completed into databases. This data will be used as future training data to teach a machine learning algorithm to associate MRS data with clinical outcomes. The company has limited sales to date.

Aclarion, Inc. (NASDAQ:ACON) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 28 items for ACON at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Aclarion's Nociscan AI Technology Wins Pinnacle Award for Innovation
  • Aclarion's Nociscan Nears 100 Scans at London Clinic, Signaling Growing Adoption
  • Aclarion Seeks Shareholder Approval for Major Equity Plan Expansion and Re-election of Contested Director
  • Activist Investor Demands Board Member Resignation at Aclarion Amid 99% Stock Decline
  • Aclarion Adopts 'Poison Pill' Stockholder Rights Plan to Deter Hostile Takeovers

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$75.73K
Net Income
-$7.23M
Diluted EPS
-$13.61
Op. Cash Flow
-$7.16M
Free Cash Flow
-$7.19M
Gross Profit
$6.83K
Operating Income
-$7.05M
Cash & Equivalents
$12.02M
Debt / Equity
0.00×
Net Margin
-95.52×
Shares Outstanding
854.37K sh
Source: 10-K · filed 2026-03-18 · accession 0001683168-26-001986
$1.34 -5.63% today
52-week range · as of 2026-11-05 $1.34 – $9.36
Market cap
$3.52M
Volume
44.9K (2.4× avg)
3-mo avg 18.4K
Live data · 2026-11-21 17:40 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ACON - Filings & News (Page 2)

ACON
Apr 14, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.15
Real-time Price: $1.34 info
Change: -$1.81 (-57%) info
Market Cap: $3.523M info
ACON
Apr 07, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $3.53
Real-time Price: $1.34 info
Change: -$2.19 (-62%) info
Market Cap: $3.523M info
ACON
Apr 03, 2026, 5:02 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $3.57
Real-time Price: $1.34 info
Change: -$2.23 (-62%) info
Market Cap: $3.523M info
ACON
Mar 24, 2026, 8:00 AM EDT
Source: Access Newswire
Importance Score:
8
Price at Filing: $3.12
Real-time Price: $1.34 info
Change: -$1.78 (-57%) info
Market Cap: $3.523M info
ACON
Mar 19, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.26
Real-time Price: $1.34 info
Change: -$1.92 (-59%) info
Market Cap: $3.523M info
ACON
Jan 13, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.19
Real-time Price: $1.34 info
Change: -$2.85 (-68%) info
Market Cap: $3.523M info
ACON
Jan 09, 2026, 9:03 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $6.86
Real-time Price: $1.34 info
Change: -$5.52 (-80%) info
Market Cap: $3.523M info
ACON
Jan 09, 2026, 9:00 AM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $7.03
Real-time Price: $1.34 info
Change: -$5.69 (-81%) info
Market Cap: $3.523M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets